1. Home
  2. Search

Search

Search results

1038 results found

Precision RNA Medicine Core Detection Workshop

News: April 29, 2022
Dr. Heng was one of the speakers at the BIDMC Precision RNA Medicine Core Detection Workshop, "Tools for the discovery and validation of clinically important microRNA biomarkers” on Friday, April 29 th at 9:00 AM – 10:30 AM ET. The title of her talk was, " “Plasma miRNAs associated with cisplatin...

College of American Pathologist (CAP) Meeting 2022

News: May 27, 2022
Congratulations to Dr Baker. Her abstract, "Comparing the Immunohistochemistry Scoring of Breast Tumor Tissue Microarrays Using Definiens, InForm, and QuPath" has been accepted for Poster presentation at the CAP annual meeting 2022.

Steven E. Labkoff, MD, FACP, FACMI, FAMIA

Person: Collaborating Scientist, Division of Clinical Informatics, BIDMC, Vice President, Development and Medical Analytics @ Bristol Myers Squibb |, Fellow of ACMI, ACP and AMIA
Steven Labkoff is one of the leading clinician-informaticians in the US today with 30 years of experience in the life sciences and healthcare sector. He has deep expertise in generating, managing, and analyzing data to accelerate drug development, personalize patient care, and improve medical...

Berkcan Ozturk, M.D.

Person: (Alumnus) Postdoctoral Fellow, currently resident in internal medicine, Mt. Auburn Hospital, Cambridge, MA
I am from Turkey. I am graduated from Hacettepe University Medical School in Turkey in July 2020. After graduation, i worked as a physician for 2 years in Istanbul. I have been interested in hormonal, genetic, environmental interaction and how it affects metabolism. I believe we can touch the people...

Novel engineered, membrane-tethered VEGF-A variants promote formation of filopodia, proliferation, survival, and cord or tube formation by endothelial cells via persistent VEGFR2/ERK signaling and activation of CDC42/ROCK pathways

Publication: Journal Article
Shen, Junhui, Franco Aparecido Rossato, Issahy Cano, and Yin Shan Eric Ng. 2021. “Novel Engineered, Membrane-Tethered VEGF-A Variants Promote Formation of Filopodia, Proliferation, Survival, and Cord or Tube Formation by Endothelial Cells via Persistent VEGFR2/ERK Signaling and Activation of CDC42/ROCK Pathways”. FASEB J 35 (12): e22036.